Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- EUR | -.--% | -.--% | -.--% |
05-28 | Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court | RE |
05-28 | Highlighting Exxon suit, investors urge firms to keep shareholder spats out of court | RE |
Strengths
- Its low valuation, with P/E ratio at 6.76 and 6.32 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company's share price in relation to its net book value makes it look relatively cheap.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The group shows a rather high level of debt in proportion to its EBITDA.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- Revenue estimates are regularly revised downwards for the current and coming years.
Ratings chart - Surperformance
Sector: Life & Health Insurance
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-.--% | 12.71B | - | ||
+6.87% | 101B | B | ||
+9.49% | 101B | B- | ||
-11.17% | 86.29B | B+ | ||
+21.65% | 76.75B | D+ | ||
+21.03% | 34.44B | B | ||
+20.29% | 30.89B | B | ||
+13.27% | 29.37B | A | ||
-3.22% | 16.64B | C+ | ||
-14.98% | 14.17B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- NN Stock
- 0QVV Stock
- Ratings NN Group